From: "Kommunikatsioon - RA" <press@ravimiamet.ee>
To: =?iso-8859-1?Q?K=E4rolin_Jenas_-_RA?= <karolin.jenas@ravimiamet.ee>
References: <DB9PR07MB9811AA3685BBDB401BBB6A1283162@DB9PR07MB9811.eurprd07.prod.outlook.com>
In-Reply-To: <DB9PR07MB9811AA3685BBDB401BBB6A1283162@DB9PR07MB9811.eurprd07.prod.outlook.com>
Subject: =?iso-8859-1?Q?Ed:_rus.Postimehe_p=E4ring?=
Date: Fri, 29 May 2026 16:39:37 +0300
Message-ID: <GV2PR02MB11921BDFDDED65B864728C076A6162@GV2PR02MB11921.eurprd02.prod.outlook.com>
MIME-Version: 1.0
Content-Type: multipart/related;
	boundary="----=_NextPart_000_00C1_01DCF04B.053B7B70"
Thread-Index: AQGQhsDSe4VJ3vNJQipeeMpPTQsMgwGt8BYy
X-MS-Exchange-Organization-ExpirationStartTime: 29 May 2026 13:39:40.5116
 (UTC)
X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit
X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000
X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit
X-MS-Exchange-Organization-Network-Message-Id: 50ee4bad-cd59-445d-8829-08debd87bbf9
X-EOPAttributedMessage: 0
X-MS-Exchange-Organization-MessageDirectionality: Originating
X-MS-PublicTrafficType: Email
X-MS-TrafficTypeDiagnostic: GV2PR02MB11921:EE_|PAVPR02MB9160:EE_|DB1PEPF000509F5:EE_|AS5PR02MB11294:EE_|VI1PR02MB5024:EE_
X-MS-Exchange-Organization-AuthSource: GV2PR02MB11921.eurprd02.prod.outlook.com
X-MS-Exchange-Organization-AuthAs: Internal
X-MS-Office365-Filtering-Correlation-Id: 50ee4bad-cd59-445d-8829-08debd87bbf9
X-MS-Exchange-AtpMessageProperties: SA
X-MS-Exchange-Organization-SCL: 1
X-Microsoft-Antispam: BCL:0;ARA:13230040|39142699007|31052699007|366016|6049299003|82310400026|35042699022|8096899003|18002099003|22082099003|55112099003|56012099006|11063799006|41050700001;
X-Forefront-Antispam-Report: CIP:13.93.42.39;CTRY:NL;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:westeu12-emailsignatures-cloud.codetwo.com;PTR:westeu12-emailsignatures-cloud.codetwo.com;CAT:NONE;SFS:(13230040)(39142699007)(31052699007)(366016)(6049299003)(82310400026)(35042699022)(8096899003)(18002099003)(22082099003)(55112099003)(56012099006)(11063799006)(41050700001);DIR:INT;
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 29 May 2026 13:39:40.4781
 (UTC)
X-MS-Exchange-CrossTenant-Network-Message-Id: 50ee4bad-cd59-445d-8829-08debd87bbf9
X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2
X-MS-Exchange-CrossTenant-AuthSource: GV2PR02MB11921.eurprd02.prod.outlook.com
X-MS-Exchange-CrossTenant-AuthAs: Internal
X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem
X-MS-Exchange-Transport-CrossTenantHeadersStamped: PAVPR02MB9160
X-MS-Exchange-Transport-CrossTenantHeadersStamped: AS5PR02MB11294
X-MS-Exchange-Transport-EndToEndLatency: 00:00:03.1941461
X-MS-Exchange-Processed-By-BccFoldering: 15.21.0071.000
X-MS-Exchange-ExternalInOutlookResult: NotEnabled
X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009189)(140003);
X-Microsoft-Antispam-Message-Info: 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
Content-Language: et
received-spf: Pass (protection.outlook.com: domain of ravimiamet.ee designates 13.93.42.39 as permitted sender) receiver=protection.outlook.com; client-ip=13.93.42.39; helo=westeu12-emailsignatures-cloud.codetwo.com; pr=C
x-ms-exchange-organization-originalclientipaddress: 45.156.32.33
x-ms-exchange-organization-originalserveripaddress: 10.167.242.151
acceptlanguage: en-US
X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|366016|39142699007|31052699007|6049299003|56012099006|11063799006|22082099003|18002099003|8096899003|55112099003|41050700001;
X-Microsoft-Antispam-Message-Info-Original: IaF36g5H3YI41wqtWq0rGHBfnD6bqpJ7KiKBkrF6OEQvGbTSgM1uxaQv1oTp+IoLMFfkXqREzMh0ElUGpJ7rPcIwNayYxNu0nnEGD9eVDyhqykS1X4S9xSS6kvao9QpSGMKuplzebC/0H5fUplEGTz/IQPMy/1upzAT2ssEHgiT0XaNZ0Js87WdILuLtaRhGc43Yb6wLLWwiOFRpZrI/z1AawbOB6ym9c1YvyfvGQvF8eGsXvL4tfKBYElVmAjSh52Ce8qS69om6qNm3JQRQ0ArQNByTZPNE94GMpoarkSxIDmiwrjETxMSzLph/TAZ6g4I+iMT2glExvpnVN35Ak+AFBDMbNKBub32hEs3br55EojXQPssB0mG6dVSOiimiubWN1aOxqrfUWQ6ReturJ6W1xopGAigMOGA9uz4/ZPyEg/yUdYqOxT/xCyCbHhZ1IX+KwJQ2l+kNAYTOwFV9UtSxUzw+t1nbS0ODFE/jTAVo8Zi6+c5sVzXeAM/kn/LCK3lGWmnrWxm+nBkxzGRnxg0OF7IxzAXOGn6xVz+I4sRJuEVuhwXKoIDVHvtz/Y983FdsMojxPYUsB3lNV3Ru/MnGxK5YxsCiUR7e/Qen8ccbD2g8oVdhLmmG5EGNElU68mNpG87pfjnKgTyn/o/U9t6ytCnLBTH92zCAhRho7kKt+7k1CY/eiCNlU5Yu54LY
X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:GV2PR02MB11921.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(366016)(39142699007)(31052699007)(6049299003)(56012099006)(11063799006)(22082099003)(18002099003)(8096899003)(55112099003)(41050700001);DIR:INT;
X-Exchange-RoutingPolicyChecked: Yb0qpJjbNOEP4WAq3wzDV32vU6eIHTu+U/b+fb0aNaNjpCvyZbVOfuD2JzMO/0kQoWTifN1+tIeBy4/jQ1taitiW+JU7nYxDK5Oc5jz/NxswEJHhquTxFS58j1fkzR/0YEetGN3f+ahhjiKGNBh7o5XzrsUkm6NtVM3E8FnxAphjbUafe4x5B2s1oGNESJY/A/3GScPx9boxP36QFilKMGaHMo1+OY7B1wQykqtmx1O4tKfa8wVgJt/Fk+hUzCVkP9jIVMZnw6gibVoGtVdQwsW3u5Rr+4Bld5qYJPbMROnLANaZmI5NT9DZPc52+VM6air5r3oqafQKTJQ8uFVOyA==
X-OrganizationHeadersPreserved: PAVPR02MB9160.eurprd02.prod.outlook.com
X-CodeTwo-MessageID: e6e1deea-bf9d-4219-976b-65e66331045a.20260529133939@westeu12-emailsignatures-cloud.codetwo.com
X-CodeTwoProcessed: true
X-MS-Exchange-Organization-AuthMechanism: 04
X-CrossPremisesHeadersPromoted: DB1PEPF000509F5.eurprd02.prod.outlook.com
X-CrossPremisesHeadersFiltered: DB1PEPF000509F5.eurprd02.prod.outlook.com
X-MS-Exchange-Transport-CrossTenantHeadersStripped: DB1PEPF000509F5.eurprd02.prod.outlook.com
X-OriginatorOrg: m1wmgpm3xrpm87txzdfw82by7.smtp.codetwo.online
X-MS-Office365-Filtering-Correlation-Id-Prvs: 508193bd-81c5-40d6-c4d6-08debd87ba17
X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;Ip=[13.93.42.39];Helo=[westeu12-emailsignatures-cloud.codetwo.com]
authentication-results-original: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee;
msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-05-29T13:39:37.529Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard;
X-OlkEid: 000000004C30E2D3CD34B4428531CBEB8A7CAB89070034AD76187591974DBF6C4F76951C873A0100020000000000B04CDEF8D3227A448511457FBBCE9C8700000000104600003D97EB8E5F741E499E95E1604888F419

This is a multipart message in MIME format.

------=_NextPart_000_00C1_01DCF04B.053B7B70
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_00C2_01DCF04B.053CB3F0"


------=_NextPart_001_00C2_01DCF04B.053CB3F0
Content-Type: text/plain;
	charset="iso-8859-1"
Content-Transfer-Encoding: 8bit


  _____

Saatja: Sofija Soldatenko <sofija.soldatenko@postimees.ee>
Saadetud: reede, 29. mai 2026 14:23
Adressaat: Kommunikatsioon - RA <press@ravimiamet.ee>
Teema: rus.Postimehe päring



Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.

Tere!


Alates 14. maist on digitaalses retseptiteenuses kasutusele võetud uus
funktsioon patsientidele, kellele on välja kirjutatud narkootilised
ravimid. Arst kirjutab välja retsepti, kuid ravimeid saab välja osta
ainult järk-järgult, mitte kõiki korraga. Kas amet võiks selgitada, kuidas
uus süsteem täpselt töötab ja mille poolest see erineb varasemast?
Millistele ravimitele see süsteem täpsemalt kehtib?







Lugupidamisega

Sofija Soldatenko

Rus.Postimees reporter

AS Postimees Grupp

sofija.soldatenko@postimees.ee




------=_NextPart_001_00C2_01DCF04B.053CB3F0
Content-Type: text/html;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable

<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; =
charset=3Diso-8859-1">
<style type=3D"text/css" style=3D"display:none;"> P =
{margin-top:0;margin-bottom:0;} </style>
</head>
<body dir=3D"ltr">
<div style=3D"font-family: Arial, Helvetica, sans-serif; font-size: =
10pt; color: rgb(0, 0, 0);" class=3D"elementToProof">
<br>
</div>
<div id=3D"appendonsend"></div>
<hr style=3D"display:inline-block;width:98%" tabindex=3D"-1">
<div id=3D"divRplyFwdMsg" dir=3D"ltr"><font face=3D"Calibri, sans-serif" =
style=3D"font-size:11pt" color=3D"#000000"><b>Saatja:</b> Sofija =
Soldatenko &lt;sofija.soldatenko@postimees.ee&gt;<br>
<b>Saadetud:</b> reede, 29. mai 2026 14:23<br>
<b>Adressaat:</b> Kommunikatsioon - RA &lt;press@ravimiamet.ee&gt;<br>
<b>Teema:</b> rus.Postimehe p=E4ring</font>
<div>&nbsp;</div>
</div>
<style type=3D"text/css" style=3D"display:none">
<!--
p
	{margin-top:0;
	margin-bottom:0}
-->
</style>
<div dir=3D"ltr">
<table class=3D"x_MsoNormalTable" border=3D"0" cellspacing=3D"0" =
cellpadding=3D"0" align=3D"left" width=3D"100%" style=3D"width:100.0%">
<tbody>
<tr style=3D"">
<td style=3D"background:#910A19; padding:5.25pt 1.5pt 5.25pt =
1.5pt"></td>
<td width=3D"100%" cellpadding=3D"7px 5px 7px 15px" color=3D"#212121" =
style=3D"width:100.0%; background:#FDF2F4; padding:5.25pt 3.75pt 5.25pt =
11.25pt; word-wrap:break-word">
<div>
<p class=3D"x_MsoNormal" style=3D""><span style=3D"font-size:9.0pt; =
font-family:&quot;Segoe UI&quot;,sans-serif; =
color:#212121"><strong>T=E4helepanu!
</strong>Tegemist on v=E4lisv=F5rgust saabunud kirjaga.<br>
Tundmatu saatja korral palume linke ja faile mitte avada.</span></p>
</div>
</td>
</tr>
</tbody>
</table>
<div>
<div class=3D"x_elementToProof" =
style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Calibri=
,Helvetica,sans-serif; color:rgb(0,0,0)">
<span style=3D"font-family:Calibri,Helvetica,sans-serif; =
font-size:11pt">Tere!</span></div>
<div class=3D"x_elementToProof" =
style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Calibri=
,Helvetica,sans-serif; color:rgb(0,0,0)">
<span style=3D"font-family:Calibri,Helvetica,sans-serif; =
font-size:11pt"><br>
</span></div>
<div class=3D"x_elementToProof" =
style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Calibri=
,Helvetica,sans-serif; color:rgb(0,0,0)">
<span style=3D"font-family:Calibri,Helvetica,sans-serif; =
font-size:11pt">Alates 14. maist on digitaalses retseptiteenuses =
kasutusele v=F5etud uus funktsioon patsientidele, kellele on v=E4lja =
kirjutatud narkootilised ravimid. Arst kirjutab v=E4lja retsepti, kuid =
ravimeid
 saab v=E4lja osta ainult j=E4rk-j=E4rgult, mitte k=F5iki korraga. Kas =
amet v=F5iks selgitada, kuidas uus s=FCsteem t=E4pselt t=F6=F6tab ja =
mille poolest see erineb varasemast? Millistele ravimitele see s=FCsteem =
t=E4psemalt kehtib?</span></div>
<div class=3D"x_elementToProof" =
style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Calibri=
,Helvetica,sans-serif; color:rgb(0,0,0)">
<span style=3D"font-family:Calibri,Helvetica,sans-serif; =
font-size:11pt"><br>
</span></div>
<div class=3D"x_elementToProof" =
style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Calibri=
,Helvetica,sans-serif; color:rgb(0,0,0)">
<span style=3D"font-family:Calibri,Helvetica,sans-serif; =
font-size:11pt"></span><span style=3D"font-size:12pt"><br>
</span></div>
<div class=3D"x_elementToProof" =
style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Calibri=
,Helvetica,sans-serif; font-size:12pt; color:rgb(0,0,0)">
<br>
</div>
<div id=3D"x_Signature">
<div =
style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Calibri=
,Helvetica,sans-serif; font-size:12pt; color:rgb(0,0,0)">
<br>
</div>
<div style=3D"margin-top:16px; margin-bottom:0px">
<p style=3D"text-align:left; line-height:15.6933px; =
background-color:white; margin:0px; font-family:Calibri,sans-serif; =
font-size:11pt; color:black">
<span style=3D"font-family:Calibri,Helvetica,sans-serif; =
color:rgb(0,100,250); line-height:normal">Lugupidamisega</span></p>
<p style=3D"text-align:left; line-height:15.6933px; =
background-color:white; margin:0px; font-size:11pt">
<span style=3D"font-family:Calibri,Helvetica,sans-serif; =
color:rgb(0,100,250)">Sofija Soldatenko</span></p>
<p style=3D"text-align:left; line-height:15.6933px; =
background-color:white; margin:0px; font-family:Calibri,sans-serif; =
font-size:11pt; color:black">
<span style=3D"font-family:Calibri,Helvetica,sans-serif; =
color:rgb(0,100,250); line-height:normal">Rus.Postimees =
reporter</span></p>
<p style=3D"text-align:left; line-height:15.6933px; =
background-color:white; margin:0px; font-family:Calibri,sans-serif; =
font-size:11pt; color:black">
<span style=3D"font-family:Calibri,Helvetica,sans-serif; =
color:rgb(0,100,250); line-height:normal">AS Postimees Grupp</span></p>
<p style=3D"text-align:left; line-height:15.6933px; =
background-color:white; margin:0px; font-family:Calibri,sans-serif; =
font-size:11pt; color:black">
<span style=3D"font-family:Calibri,Helvetica,sans-serif; =
color:rgb(0,100,250); =
line-height:normal">sofija.soldatenko@postimees.ee</span></p>
<div style=3D"font-size:12pt"><br>
</div>
</div>
<div style=3D"margin-top:16px; margin-bottom:0px; =
font-family:Calibri,Arial,Helvetica,sans-serif; font-size:12pt; =
color:rgb(0,0,0)">
<img style=3D"max-width:100%" data-outlook-trace=3D"F:2|T:2" =
src=3D"cid:4051691d-6bde-42ef-982e-487a28fdb43a"></div>
</div>
</div>
</div>
</body>
</html>

------=_NextPart_001_00C2_01DCF04B.053CB3F0--

------=_NextPart_000_00C1_01DCF04B.053B7B70
Content-Type: image/png;
	name="Outlook-d4wlsdc3.png"
Content-Transfer-Encoding: base64
Content-ID: <4051691d-6bde-42ef-982e-487a28fdb43a>
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------=_NextPart_000_00C1_01DCF04B.053B7B70--